Cargando…
Paclitaxel-Coated Balloon Angioplasty for the Treatment of Infrainguinal Arteries: 24-Month Outcomes in the Full Cohort of BIOLUX P-III Global Registry
PURPOSE: After promising small randomized trials, the aim of BIOLUX P-III was to further investigate the safety and performance of the Passeo-18 lx drug-coated balloon in infrainguinal arteries under real-world conditions. METHODS: BIOLUX P-III is a global prospective single-arm study with follow-up...
Autores principales: | Tepe, Gunnar, Zeller, Thomas, Moscovic, Matej, Corpataux, Jean-Marc, Christensen, Johnny Kent, Keirse, Koen, Nano, Giovanni, Schroeder, Henrik, Binkert, Christoph A., Brodmann, Marianne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806550/ https://www.ncbi.nlm.nih.gov/pubmed/33083853 http://dx.doi.org/10.1007/s00270-020-02663-7 |
Ejemplares similares
-
Correction to: Paclitaxel-Coated Balloon Angioplasty for the Treatment of Infrainguinal Arteries: 24-Month Outcomes in the Full Cohort of BIOLUX P-III Global Registry
por: Tepe, Gunnar, et al.
Publicado: (2021) -
Paclitaxel-Coated Balloon for the Treatment of Infrainguinal Disease: 12-Month Outcomes in the All-Comers Cohort of BIOLUX P-III Global Registry
por: Tepe, Gunnar, et al.
Publicado: (2020) -
Real-world experience with a Paclitaxel-Coated Balloon for the treatment of atherosclerotic infrainguinal arteries: 12-month interim results of the BIOLUX P-III registry first year of enrolment
por: Brodmann, Marianne, et al.
Publicado: (2017) -
Sex-Related Outcomes Following Drug Balloon Angioplasty in Patients from the BIOLUX P-III Registry: A Subgroup Analysis
por: Barry, Ian Patrick, et al.
Publicado: (2022) -
Endovascular balloon angioplasty for infrainguinal arterial occlusive disease: Efficacy analysis
por: Sarıcaoğlu, Mehmet Cahit, et al.
Publicado: (2021)